EW
Edwards Lifesciences Corporation
Stock
$85.15−0.04 (−0.05%)Close Oct 2, 2026
- Research and development, 2025
- $1.1B
- YoY, 2025
- +2.5%
- 5-year CAGR
- +7.2%
- 10-year CAGR
- +10.9%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $1.1B | +2.5% |
| 2024 | $1.1B | +9.4% |
| 2023 | $963M | +14.1% |
| 2022 | $844M | −6.6% |
| 2021 | $903M | +18.7% |
| 2020 | $761M | +1.1% |
| 2019 | $753M | +21.0% |
| 2018 | $622M | +12.6% |
| 2017 | $553M | +25.0% |
| 2016 | $442M | +15.5% |
| 2015 | $383M | +10.5% |
| 2014 | $347M | +7.3% |
| 2013 | $323M | +10.9% |
| 2012 | $291M | +18.3% |
| 2011 | $246M | +20.5% |
| 2010 | $204M | +16.5% |
| 2009 | $176M | +26.1% |
| 2008 | $139M | — |